Skip to main content

Gyre Therapeutics, Inc.

GYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001124105

No open-market purchases or sales by Gyre Therapeutics, Inc. insiders were filed in the last 90 days; 59 institutions reported holding it in 13F filings for Q2 2026, worth $57.1M in total; no superinvestor holds it.

13F holders, Q4 2024

Institutional positions in Gyre Therapeutics, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
41
+4 vs. Q3 2024
Shares held
1.79M
+177.0K (+11.0%) vs. Q3 2024
Total value
$21.6M
+$1.43M (+7.1%) vs. Q3 2024
New holders
6
17 more added
Sold out
2
11 more reduced

Compare with Q3 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting GYRE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2024: 41 institutions
Q1 2021: 89 institutionsQ2 2021: 69 institutionsQ3 2021: 66 institutionsQ4 2021: 51 institutionsQ1 2022: 43 institutionsQ2 2022: 41 institutionsQ3 2022: 35 institutionsQ4 2022: 35 institutionsQ1 2023: 40 institutionsQ2 2023: 29 institutionsQ3 2023: 32 institutionsQ4 2023: 16 institutionsQ1 2024: 21 institutionsQ2 2024: 30 institutionsQ3 2024: 37 institutionsQ4 2024: 41 institutionsQ1 2025: 46 institutionsQ2 2025: 48 institutionsQ3 2025: 48 institutionsQ4 2025: 44 institutionsQ1 2026: 56 institutionsQ2 2026: 59 institutions
Value heldQ4 2024: $21.6M
Q1 2021: $113.0MQ2 2021: $87.7MQ3 2021: $75.7MQ4 2021: $13.7MQ1 2022: $6.39MQ2 2022: $14.2MQ3 2022: $3.90MQ4 2022: $2.63MQ1 2023: $707.6KQ2 2023: $796.3KQ3 2023: $1.04MQ4 2023: $15.6MQ1 2024: $14.3MQ2 2024: $15.0MQ3 2024: $20.2MQ4 2024: $21.6MQ1 2025: $20.1MQ2 2025: $25.1MQ3 2025: $23.1MQ4 2025: $23.6MQ1 2026: $23.8MQ2 2026: $57.1M
Institutions holding GYRE and their total value by quarter
QuarterHoldersValue
Q2 202659$57.1M
Q1 202656$23.8M
Q4 202544$23.6M
Q3 202548$23.1M
Q2 202548$25.1M
Q1 202546$20.1M
Q4 202441$21.6M
Q3 202437$20.2M
Q2 202430$15.0M
Q1 202421$14.3M
Q4 202316$15.6M
Q3 202332$1.04M
Q2 202329$796.3K
Q1 202340$707.6K
Q4 202235$2.63M
Q3 202235$3.90M
Q2 202241$14.2M
Q1 202243$6.39M
Q4 202151$13.7M
Q3 202166$75.7M
Q2 202169$87.7M
Q1 202189$113.0M

Institutions, Q4 2024

Shares, value and share of portfolio for each institution holding Gyre Therapeutics, Inc.; share changes are against Q3 2024.

Institutions holding GYRE in Q4 2024
InstitutionSharesValue% of portfolioChange in sharesAction
BlackRock, Inc.531,680$6.43M0.00%+17,259+3.4%Added
Vanguard Group Inc322,464$3.90M0.00%−17,707−5.2%Reduced
Geode Capital Management, LLC304,098$3.68M0.00%+451+0.1%Added
State Street Corp126,647$1.53M0.00%+22,157+21.2%Added
Charles Schwab Investment Management Inc114,566$1.39M0.00%+918+0.8%Added
Northern Trust Corp103,382$1.25M0.00%+8,624+9.1%Added
SBI Securities Co., Ltd.101,239$1.22M0.04%+101,239New
UBS Group AG57,084$690.7K0.00%+53,441+1,467.0%Added
Goldman Sachs Group Inc26,386$319.3K0.00%+7,587+40.4%Added
Morgan Stanley15,241$184.4K0.00%−2,981−16.4%Reduced
Bank of New York Mellon Corp13,896$168.1K0.00%+1,389+11.1%Added
Barclays PLC10,543$127.6K0.00%+1,255+13.5%Added
Rhumbline Advisers10,432$126.2K0.00%+8+0.1%Added
Advantage Alpha Capital Partners LP8,873$107.4K0.03%−17,761−66.7%Reduced
Bank of America Corp6,937$83.9K0.00%+1,996+40.4%Added
Citigroup Inc5,399$65.3K0.00%+323+6.4%Added
Wells Fargo & Company4,016$48.6K0.00%+913+29.4%Added
Mirae Asset Global ETFs Holdings Ltd.4,013$48.6K0.00%+152+3.9%Added
Corebridge Financial, Inc.3,468$42.0K0.00%−262−7.0%Reduced
JPMorgan Chase & Co3,269$39.6K0.00%+237+7.8%Added
New York State Common Retirement Fund2,700$32.7K0.00%00.0%Unchanged
Belvedere Trading LLC2,461$29.8K0.00%−54−2.1%Reduced
BNP Paribas Arbitrage, SA1,394$16.9K0.00%−553−28.4%Reduced
FMR LLC1,256$15.2K0.00%−2,486−66.4%Reduced
Picton Mahoney Asset Management1,120$14.0K0.00%+1,120New
Tower Research Capital LLC (TRC)852$10.3K0.00%−6−0.7%Reduced
Royal Bank of Canada810$10.0K0.00%−154−16.0%Reduced
Ameritas Investment Partners, Inc.683$8.26K0.00%00.0%Unchanged
Legal & General Group Plc603$7.29K0.00%00.0%Unchanged
Activest Wealth Management533$6.45K0.00%00.0%Unchanged
California State Teachers Retirement System505$6.11K0.00%00.0%Unchanged
Amalgamated Bank241$3.00K0.00%00.0%Unchanged
Sterling Capital Management LLC216$2.61K0.00%+195+928.6%Added
Nisa Investment Advisors, LLC84$1.02K0.00%00.0%Unchanged
Federation des caisses Desjardins du Quebec75$9080.00%+75New
Advisor Group Holdings, Inc.41$4960.00%−400−90.7%Reduced
Parallel Advisors, LLC15$1820.00%+15New
GAMMA Investing LLC12$1450.00%+12New
IFP Advisors, Inc2$240.00%+2New
CWM, LLC15$00.00%−15−50.0%Reduced
Covestor Ltd7$00.00%+1+16.7%Added
Capital Performance Advisors LLP0$00.00%−6−100.0%Sold out
Danske Bank A/S0$00.00%−1−100.0%Sold out